- Home
- EVTV vs VRAX Comparison
EVTV vs VRAX Comparison
Compare EVTV & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- VRAX
- Stock Information
- Founded
- EVTV 2012
- VRAX 2013
- Country
- EVTV United States
- VRAX United Kingdom
- Employees
- EVTV N/A
- VRAX N/A
- Industry
- EVTV Auto Manufacturing
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EVTV Consumer Discretionary
- VRAX Health Care
- Exchange
- EVTV Nasdaq
- VRAX Nasdaq
- Market Cap
- EVTV 5.1M
- VRAX 4.7M
- IPO Year
- EVTV 2017
- VRAX 2022
- Fundamental
- Price
- EVTV $0.18
- VRAX $0.85
- Analyst Decision
- EVTV
- VRAX Strong Buy
- Analyst Count
- EVTV 0
- VRAX 1
- Target Price
- EVTV N/A
- VRAX $3.00
- AVG Volume (30 Days)
- EVTV 1.7M
- VRAX 37.2K
- Earning Date
- EVTV 08-13-2025
- VRAX 02-05-2025
- Dividend Yield
- EVTV N/A
- VRAX N/A
- EPS Growth
- EVTV N/A
- VRAX N/A
- EPS
- EVTV N/A
- VRAX N/A
- Revenue
- EVTV $1,650,137.00
- VRAX $6,331.00
- Revenue This Year
- EVTV N/A
- VRAX $5,169.18
- Revenue Next Year
- EVTV N/A
- VRAX $66.97
- P/E Ratio
- EVTV N/A
- VRAX N/A
- Revenue Growth
- EVTV N/A
- VRAX 7.03
- 52 Week Low
- EVTV $0.15
- VRAX $0.74
- 52 Week High
- EVTV $2.61
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- EVTV 43.36
- VRAX 45.02
- Support Level
- EVTV $0.16
- VRAX $0.74
- Resistance Level
- EVTV $0.20
- VRAX $0.88
- Average True Range (ATR)
- EVTV 0.02
- VRAX 0.07
- MACD
- EVTV 0.00
- VRAX 0.01
- Stochastic Oscillator
- EVTV 46.67
- VRAX 50.23
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.